Abstract
Given the malleable nature of cancer cells, we should expect, and do see, the development of resistance to any new chemotherapeutic agent. Models that help us understand how this happens are a first step to better and more effective chemotherapeutics. © 2012 American Association for Cancer Research.
Cite
CITATION STYLE
APA
Fojo, T., & Bates, S. (2013). Mechanisms of resistance to PARP inhibitors-three and counting. Cancer Discovery, 3(1), 20–23. https://doi.org/10.1158/2159-8290.CD-12-0514
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free